| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Unit of Environmental Carcinogens and Host Factors, International Agency for Research on Cancer, 150 cours Albert-Thomas, 69372 Lyon Cedex 08, France [K. A., M. R., O. G., M. C., A-M. C., H. B.], and Consiglio Nazionale delle Ricerche Institute of Clinical Physiology and 2nd Medical Clinic, University of Pisa, Italy [S. P., C. G.]
An improved high-performance liquid chromatography/fluorometric assay has been established to quantitate the benzo(a)pyrene (BP) tetrols released after acid hydrolysis of lung DNA from lung cancer patients, so that the formation of benzo(a)pyrene diol-epoxide-DNA adducts can be measured. The r-7,c-10,t-8,t-9-tetrahydroxy-7,8,9,10-tetrahydro-BP isolated by high-performance liquid chromatography was determined by chromatography in two different solvent systems and fluorescence spectroscopy. This assay has a detection limit of 2 pg of r-7,c-10,t-8,t-9-tetrahydroxy-7,8,9,10-tetrahydro-BP, requires 100500 µg of DNA, and can measure 1 adduct/108 unmodified nucleotides. As this assay does not use immunoaffinity chromatography or solvent extraction, it allows a >90% recovery of benzo(a)pyrene diol-epoxide-DNA adducts. This procedure has been tested on 13 DNA samples prepared from nontumorous lung parenchyma taken from lung cancer patients at surgery and revealed the presence of DNA adducts of the anti-benzo(a)-pyrene diol-epoxide in 9 of 11 samples from smokers and in 2 of 2 exsmokers. In only two samples from smokers the formation of adducts derived from syn-benzo(a)pyrene diol-epoxide was detected. A 15-fold variation in DNA adduct level was found in 11 of 13 DNA samples, with a range of 0.69.9 adducts of benzo(a)pyrene diol-epoxide/108 nucleotides. In samples containing both anti- and syn-benzo(a)pyrene diol-epoxide-DNA adducts, the anti/syn adduct ratio is 2:1. A highly significant correlation was found between pulmonary microsomal aryl hydrocarbon hydroxylase activity and the level of benzo(a)pyrene diol-epoxide-DNA adduct (r = 0.91; P < 0.001; n = 13). A crude linear correlation between the amounts of these adducts and those of bulky DNA adducts determined by 32P-postlabeling assay was observed in the same samples (r = 0.78; P < 0.02; n = 13). Thus this highly sensitive and specific procedure is suitable for measuring benzo(a)pyrene diol-epoxide-DNA adducts in human tissues from environmentally exposed subjects and could be adapted to measure polycyclic aromatic hydrocarbons other than BP.
1 Supported in part by a grant from la Ligue Nationale Française contre le Cancer, Section Rhône Alpes region; also supported in part by the CNR of Italy Special Project "Oncology" and by the CNR Cardiorespiratory National Group.
2 Visiting scientist on leave from Centre National de la Recherche Scientifique, Département des Sciences de la Vie, Section 21, 15 quai Anatole France, 75007 Paris, France.
3 To whom requests for reprints should be addressed.
Received 5/11/92. Accepted 9/ 9/92.
This article has been cited by other articles:
![]() |
X Qin, Y Wu, W Wang, T Liu, L Wang, Y Hu, and D Chen Low organic solvent exposure and combined maternal-infant gene polymorphisms affect gestational age Occup. Environ. Med., July 1, 2008; 65(7): 482 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wang, S. Chanock, D. Tang, Z. Li, W. Jedrychowski, and F. P. Perera Assessment of Interactions between PAH Exposure and Genetic Polymorphisms on PAH-DNA Adducts in African American, Dominican, and Caucasian Mothers and Newborns Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 405 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gyorffy, L. Anna, K. Kovacs, P. Rudnai, and B. Schoket Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts Mutagenesis, January 1, 2008; 23(1): 1 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wu, Y. Hu, C. Chen, F. Yang, Z. Li, Z. Fang, L. Wang, and D. Chen Passive Smoking, Metabolic Gene Polymorphisms, and Infant Birth Weight in a Prospective Cohort Study of Chinese Women Am. J. Epidemiol., August 1, 2007; 166(3): 313 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Alexandrov, M. Rojas, and C. Rolando DNA Damage by Benzo(a)pyrene in Human Cells Is Increased by Cigarette Smoke and Decreased by a Filter Containing Rosemary Extract, Which Lowers Free Radicals Cancer Res., December 15, 2006; 66(24): 11938 - 11945. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht, M. Chen, A. Yoder, J. Jensen, D. Hatsukami, C. Le, and S. G. Carmella Longitudinal Study of Urinary Phenanthrene Metabolite Ratios: Effect of Smoking on the Diol Epoxide Pathway Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2969 - 2974. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Perera, D. Tang, R. Whyatt, S. A. Lederman, and W. Jedrychowski DNA Damage from Polycyclic Aromatic Hydrocarbons Measured by Benzo[a]pyrene-DNA Adducts in Mothers and Newborns from Northern Manhattan, The World Trade Center Area, Poland, and China Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 709 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Bocskay, D. Tang, M. A. Orjuela, X. Liu, D. P. Warburton, and F. P. Perera Chromosomal Aberrations in Cord Blood Are Associated with Prenatal Exposure to Carcinogenic Polycyclic Aromatic Hydrocarbons Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 506 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Mooney, A. M. Madsen, D. Tang, M. A. Orjuela, W.-Y. Tsai, E. R. Garduno, and F. P. Perera Antioxidant Vitamin Supplementation Reduces Benzo(a)pyrene-DNA Adducts and Potential Cancer Risk in Female Smokers Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 237 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Georgiadis, J. Topinka, D. Vlachodimitropoulos, M. Stoikidou, M. Gioka, G. Stephanou, H. Autrup, N. A. Demopoulos, K. Katsouyanni, R. Sram, et al. Interactions between CYP1A1 polymorphisms and exposure to environmental tobacco smoke in the modulation of lymphocyte bulky DNA adducts and chromosomal aberrations Carcinogenesis, January 1, 2005; 26(1): 93 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Van Schooten, A. W. Boots, A. M. Knaapen, R. W. L. Godschalk, L. M. Maas, P. J. A. Borm, M. Drent, and J. A. Jacobs Myeloperoxidase (MPO) -463G->A Reduces MPO Activity and DNA Adduct Levels in Bronchoalveolar Lavages of Smokers Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 828 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ramos-Gomez, P. M. Dolan, K. Itoh, M. Yamamoto, and T. W. Kensler Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice Carcinogenesis, March 1, 2003; 24(3): 461 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Goldman and P. G. Shields Food Mutagens J. Nutr., March 1, 2003; 133(3): 965S - 973. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Alexandrov, I. Cascorbi, M. Rojas, G. Bouvier, E. Kriek, and H. Bartsch CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation Carcinogenesis, December 1, 2002; 23(12): 1969 - 1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Phillips Smoking-related DNA and protein adducts in human tissues Carcinogenesis, December 1, 2002; 23(12): 1979 - 2004. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Godschalk, J. Nair, F.J. van Schooten, A. Risch, P. Drings, K. Kayser, H. Dienemann, and H. Bartsch Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking Carcinogenesis, December 1, 2002; 23(12): 2081 - 2086. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, B. Zuckerman, C. Pearson, G. Kaufman, C. Chen, G. Wang, T. Niu, P. H. Wise, H. Bauchner, and X. Xu Maternal Cigarette Smoking, Metabolic Gene Polymorphism, and Infant Birth Weight JAMA, January 9, 2002; 287(2): 195 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schwerdtle, A. Seidel, and A. Hartwig Effect of soluble and particulate nickel compounds on the formation and repair of stable benzo[a]pyrene DNA adducts in human lung cells Carcinogenesis, January 1, 2002; 23(1): 47 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cauchi, I. Stucker, C. Solas, P. Laurent-Puig, S. Cenee, D. Hemon, M. Jacquet, P. Kremers, P. Beaune, and L. Massaad-Massade Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer Carcinogenesis, November 1, 2001; 22(11): 1819 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Yoon, L. E. Smith, Z. Feng, M.-s. Tang, C.-S. Lee, and G. P. Pfeifer Methylated CpG Dinucleotides Are the Preferential Targets for G-to-T Transversion Mutations Induced by Benzo[a]pyrene Diol Epoxide in Mammalian Cells: Similarities with the p53 Mutation Spectrum in Smoking-associated Lung Cancers Cancer Res., October 1, 2001; 61(19): 7110 - 7117. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Matsuzoe, T. Hideshima, A. Iwasaki, S. Yoneda, K. Kawahara, T. Shirakusa, and A. Kimura Glutathione S-transferase {micro}1 null genotype is associated with K-ras gene mutation in lung adenocarcinoma among smokers Carcinogenesis, August 1, 2001; 22(8): 1327 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rojas, R. Godschalk, K. Alexandrov, I. Cascorbi, E. Kriek, J. Ostertag, F.-J. Van Schooten, and H. Bartsch Myeloperoxidase - 463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients Carcinogenesis, July 1, 2001; 22(7): 1015 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hainaut and G. P. Pfeifer Patterns of p53 G{->}T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke Carcinogenesis, March 1, 2001; 22(3): 367 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R.K. Sticha, M. E. Staretz, M. Wang, H. Liang, P. M.J. Kenney, and S. S. Hecht Effects of benzyl isothiocyanate and phenethyl isothiocyanate on benzo[a]pyrene metabolism and DNA adduct formation in the A/J mouse Carcinogenesis, September 1, 2000; 21(9): 1711 - 1719. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Nia, L. M. Maas, S. G. J. Van Breda, D. M. J. Curfs, J. C. S. Kleinjans, E. F. M. Wouters, and F. J. Van Schooten Applicability of Induced Sputum for Molecular Dosimetry of Exposure to Inhalatory Carcinogens: 32P-Postlabeling of Lipophilic DNA Adducts in Smokers and Nonsmokers Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 367 - 372. [Abstract] [Full Text] |
||||
![]() |
H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28. [Abstract] [Full Text] |
||||
![]() |
M. Rojas, I. Cascorbi, K. Alexandrov, E. Kriek, G. Auburtin, L. Mayer, A. Kopp-Schneider, I. Roots, and H. Bartsch Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism Carcinogenesis, January 1, 2000; 21(1): 35 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht Tobacco Smoke Carcinogens and Lung Cancer J Natl Cancer Inst, July 21, 1999; 91(14): 1194 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mollerup, D. Ryberg, A. Hewer, D. H. Phillips, and A. Haugen Sex Differences in Lung CYP1A1 Expression and DNA Adduct Levels among Lung Cancer Patients Cancer Res., July 1, 1999; 59(14): 3317 - 3320. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ozawa, B. Schoket, L.P. McDaniel, Y.-M. Tang, C. B. Ambrosone, S. Kostic, I. Vincze, and F. F. Kadlubar Analyses of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases Carcinogenesis, June 1, 1999; 20(6): 991 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Izzotti, R. M. Balansky, P. M. Blagoeva, Z. I. Mircheva, L. Tulimiero, C. Cartiglia, and S. D. Flora DNA alterations in rat organs after chronic exposure to cigarette smoke and/or ethanol ingestion FASEB J, June 1, 1998; 12(9): 753 - 758. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |